Pocrm: An R-package for Phase I trials of combinations of agents

Computer Methods and Programs in Biomedicine

Volumn 112, Issue 1, 2013, Pages 211-218

  Wages, Nolan A ^a   Varhegyi, Nikole ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Continual reassessment method; Dose finding; Drug combination; Partial ordering; Phase I trials

Indexed keywords

CONTINUAL REASSESSMENT METHOD; DOSE FINDING; DRUG COMBINATIONS; PARTIAL ORDER; PHASE I;

COMPUTER APPLICATIONS;

SOFTWARE ENGINEERING;

ALGORITHM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); DOSE CALCULATION; HUMAN; PARTIAL ORDER CONTINUAL REASSESSMENT METHOD; PHARMACOLOGICAL PARAMETERS; PHASE 1 CLINICAL TRIAL (TOPIC); PROBABILITY; SAMPLE SIZE;

CONTINUAL REASSESSMENT METHOD; DOSE FINDING; DRUG COMBINATION; PARTIAL ORDERING; PHASE I TRIALS;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANCER VACCINES; CLINICAL TRIALS, PHASE I AS TOPIC; COMPUTER SIMULATION; FREUND'S ADJUVANT; HUMANS; LIPIDS; MAXIMUM TOLERATED DOSE; MELANOMA; NEOPLASMS; SOFTWARE; TOLL-LIKE RECEPTORS;

EID: 84883818911     PISSN: 01692607     EISSN: 18727565     Source Type: Journal    
DOI: 10.1016/j.cmpb.2013.05.020     Document Type: Article

References (11)

1. Wages N., Conaway M., O'Quigley J. Continual Reassessment Method for Partial Ordering. Biometrics 2011, 67:1555-1563.
2. Wages N., Conaway M., O'Quigley J. Dose-finding design for multi-drug combinations. Clinical Trials 2011, 8:380-389.
3. R Development Core Team R: A Language and Environment for Statistical Computing 2012, R Foundation for Statistical Computing, Vienna, Austria, ISBN: 3-900051-07-0, http://www.R-project.org/.
4. Wages N., Conaway M., O'Quigley J. Using the time-to-event continual reassessment method in the presence of partial orders. Statistics in Medicine 2013, 32:131-141.
5. Wages N., Conaway M. Specifications of a continual reassessment method design for phase I trials of combined drugs. Pharmaceutical Statistics 2013, 10.1002/pst.1575.
6. Chevret S. The continual reassessment method in cancer phase I clinical trials: a simulation study. Statistics in Medicine 1993, 12:1093-1108.
7. Paoletti X., Kramar A. A comparison of model choices for the continual reassessment method in phase I cancer trials. Statistics in Medicine 2009, 28:3012-3028.
8. O'Quigley J., Zohar S. Retrospective robustness of the continual reassessment method. Journal of Biopharmaceutical Statistics 2010, 20:1013-1025.
9. Iasonos A., O'Quigley J. Interplay of priors and skeletons in two-stage continual reassessment method. Statistics in Medicine 2012, 31:4321-4336.
10. Lee S.M., Cheung Y.K. Model calibration in the continual reassessment method. Clinical Trials 2009, 6:227-238.
11. O'Quigley J., Shen L. Continual reassessment method: a likelihood approach. Biometrics 1996, 52:673-684.